ARKAY Therapeutics

ARKAY Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative orally active combination products for the treatment of type 2 diabetes and related conditions. ARKAY's mission is to provide lasting glycemic control for patients with type 2 diabetes. We are committed to the development and commercialization of personalized medicines for type 2 diabetes, prediabetes, and metabolic disease-related conditions such as NASH (nonalcoholic steatohepatitis).